Menu
GeneBe

rs144092780

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_005051.3(QARS1):c.1426G>A(p.Val476Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00206 in 1,614,166 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 7 hom. )

Consequence

QARS1
NM_005051.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 3.13
Variant links:
Genes affected
QARS1 (HGNC:9751): (glutaminyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. In metazoans, 9 aminoacyl-tRNA synthetases specific for glutamine (gln), glutamic acid (glu), and 7 other amino acids are associated within a multienzyme complex. Although present in eukaryotes, glutaminyl-tRNA synthetase (QARS) is absent from many prokaryotes, mitochondria, and chloroplasts, in which Gln-tRNA(Gln) is formed by transamidation of the misacylated Glu-tRNA(Gln). Glutaminyl-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010393411).
BP6
Variant 3-49099610-C-T is Benign according to our data. Variant chr3-49099610-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 380083.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=3, Benign=1}. Variant chr3-49099610-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00162 (246/152304) while in subpopulation NFE AF= 0.00275 (187/68032). AF 95% confidence interval is 0.00243. There are 0 homozygotes in gnomad4. There are 97 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
QARS1NM_005051.3 linkuse as main transcriptc.1426G>A p.Val476Ile missense_variant 16/24 ENST00000306125.12
QARS1NM_001272073.2 linkuse as main transcriptc.1393G>A p.Val465Ile missense_variant 16/24
QARS1XM_017006965.3 linkuse as main transcriptc.1426G>A p.Val476Ile missense_variant 16/23
QARS1NR_073590.2 linkuse as main transcriptn.1401G>A non_coding_transcript_exon_variant 16/24

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
QARS1ENST00000306125.12 linkuse as main transcriptc.1426G>A p.Val476Ile missense_variant 16/241 NM_005051.3 P1P47897-1

Frequencies

GnomAD3 genomes
AF:
0.00162
AC:
246
AN:
152186
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00547
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00275
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00162
AC:
408
AN:
251388
Hom.:
1
AF XY:
0.00169
AC XY:
230
AN XY:
135858
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.00387
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00265
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00232
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.00211
AC:
3086
AN:
1461862
Hom.:
7
Cov.:
35
AF XY:
0.00208
AC XY:
1510
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.000313
Gnomad4 ASJ exome
AF:
0.00413
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00234
Gnomad4 FIN exome
AF:
0.000337
Gnomad4 NFE exome
AF:
0.00238
Gnomad4 OTH exome
AF:
0.00151
GnomAD4 genome
AF:
0.00162
AC:
246
AN:
152304
Hom.:
0
Cov.:
32
AF XY:
0.00130
AC XY:
97
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.000337
Gnomad4 AMR
AF:
0.000719
Gnomad4 ASJ
AF:
0.00547
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00166
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.00275
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00248
Hom.:
2
Bravo
AF:
0.00147
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00180
AC:
218
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00256
EpiControl
AF:
0.00237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxSep 24, 2021This variant is associated with the following publications: (PMID: 28620870, 27572814) -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicFeb 15, 2023- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2023QARS1: BP4 -
QARS1-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesNov 13, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeDec 01, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.60
Cadd
Benign
17
Dann
Benign
0.49
DEOGEN2
Benign
0.25
T;.;T
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.69
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.87
D;D;D
M_CAP
Benign
0.0097
T
MetaRNN
Benign
0.010
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.18
N;.;.
MutationTaster
Benign
0.98
D;D
PrimateAI
Benign
0.47
T
PROVEAN
Benign
0.060
N;N;.
REVEL
Benign
0.14
Sift
Benign
1.0
T;T;.
Sift4G
Benign
0.88
T;T;T
Polyphen
0.70
P;.;.
Vest4
0.26
MVP
0.14
MPC
0.72
ClinPred
0.018
T
GERP RS
4.1
Varity_R
0.066
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144092780; hg19: chr3-49137043; API